UNITED STATES SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549
                                    FORM 10-Q

(Mark One)

[X]  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
      EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2001

                                       OR

[ ]  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
      EXCHANGE ACT OF 1934

For the transition period from                      to
                               --------------------   -------------------

Commission file number 1-9341

                                  HOWTEK, INC.
             (Exact name of registrant as specified in its charter)

          Delaware                                      02-0377419
(State or other jurisdiction                (I.R.S. Employer Identification No.)
of incorporation or organization)

21 Park Avenue, Hudson, New Hampshire                                   03051
(Address of principal executive offices)                              (Zip Code)

                                 (603) 882-5200
              (Registrant's telephone number, including area code)

                                 Not Applicable
     (Former name, former address and former fiscal year, if changed since
                                  last report)

     Indicate  by check mark  whether the  registrant  (1) has filed all reports
required to be filed by Section 13 or 15(d) of the  Securities  Exchange  Act of
1934  during  the  preceding  12 months  (or for such  shorter  period  that the
registrant was required to file such reports),  and (2) has been subject to such
filing requirement for the past 90 days. YES X NO . --- ---

     As of the close of  business  on  November  9, 2001 there  were  14,568,900
shares outstanding of the issuer's Common Stock, $.01 par value.



                                  HOWTEK, INC.

                                      INDEX

                                                                         PAGE
PART I   FINANCIAL INFORMATION

  Item 1 Financial Statements

         Balance Sheets as of September 30, 2001
         (unaudited) and December 31, 2000                                    3

         Statements of  Operations  for the three month  periods  ended
         September  30,  2001 and 2000 and for the nine month  periods
         ended September 30, 2001 and 2000 (unaudited)                        4

         Statements of Cash Flows for the nine month periods
         ended September 30, 2001 and 2000 (unaudited)                        5

         Notes to Financial Statements (unaudited)                          6-7

  Item 2 Management's Discussion and Analysis of
             Financial Condition and Results of Operations                 8-11

  Item 3 Quantitative and Qualitative Disclosures about Market Risk          11



PART II  OTHER INFORMATION

  Item 2     Sale of Securities and Use of Proceeds                          12

  Item 4     Submission of Matters to a Vote of Security Holders          12-13

  Item 6     Exhibits and Reports on Form 8-K                                13



  Signatures                                                                 14


                                       2



                                  HOWTEK, INC.

                                 Balance Sheets



                                                                September 30, 2001      December 31, 2000
                                                               --------------------    --------------------
                         Assets                                    (unaudited)              (audited)
                                                                                    
Current assets:
  Cash and equivalents                                             $    257,040           $  1,444,771
  Trade accounts receivable, net of allowance
    for doubtful accounts of $225,000 in 2001
    and $256,000 in 2000                                              1,018,038              1,082,783
  Inventory                                                           2,932,462              2,443,150
  Prepaid and other                                                      48,580                111,312
                                                                   ------------           ------------
      Total current assets                                            4,256,120              5,082,016
                                                                   ------------           ------------

Property and equipment:
  Equipment                                                           2,920,288              2,843,818
  Leasehold improvements                                                 41,721                 36,821
  Motor vehicles                                                             --                  6,050
                                                                   ------------           ------------
                                                                      2,962,009              2,886,689
  Less accumulated depreciation and amortization                      2,575,956              2,398,553
                                                                   ------------           ------------
      Net property and equipment                                        386,053                488,136
                                                                   ------------           ------------

Other assets:
  Software development costs, net                                       281,425                350,550
  Debt issuance costs, net                                                4,241                 16,965
  Patents, net                                                            4,882                  8,261
                                                                   ------------           ------------
      Total other assets                                                290,548                375,776
                                                                   ------------           ------------

      Total assets                                                 $  4,932,721           $  5,945,928
                                                                   ============           ============


          Liabilities and Stockholders' Equity

Current liabilities:
  Accounts payable                                                 $  1,357,460           $  1,096,174
  Accrued expenses                                                      558,081                430,699
  Loans payable to related party                                        500,000                500,000
  Convertible subordinated debentures                                   117,000                117,000
  Current maturities of note payable                                     64,497                     --
                                                                   ------------           ------------
      Total current liabilities                                       2,597,038              2,143,873

Loans payable to related party                                          195,693                900,000
Note payable                                                            128,995                     --
                                                                   ------------           ------------
      Total liabilities                                               2,921,726              3,043,873
                                                                   ------------           ------------


Stockholders' equity:
  Convertible preferred stock, $.01 par value: authorized
    1,000,000 shares; issued and outstanding
    9,550, with the aggregated liquidation value
    of $2,215,000 plus 7% annual dividend                                    96                     96
  Common stock, $ .01 par value:  authorized
    25,000,000 shares; issued 14,636,776 in 2001
    and 13,588,126 shares in 2000; outstanding
    14,568,900 in 2001 and 13,520,250 shares in 2000                    146,367                135,881
  Additional paid-in capital                                         56,449,684             55,365,491
  Accumulated deficit                                               (53,634,888)           (51,649,149)
  Treasury stock, at cost (67,876 shares)                              (950,264)              (950,264)
                                                                   ------------           ------------
      Total stockholders' equity                                      2,010,995              2,902,055
                                                                   ------------           ------------

      Total liabilities and stockholders' equity                   $  4,932,721           $  5,945,928
                                                                   ============           ============


See accompanying notes to financial statements.


                                       3


                                  HOWTEK, INC.

                            Statements of Operations



                                                      Three Months Ended                    Nine Months Ended
                                                         September 30,                        September 30,
                                               -------------------------------       -------------------------------
                                                    2001              2000               2001                2000
                                                          (unaudited)                           (unaudited)
                                                                                            
Sales                                          $  1,139,025       $  2,760,773       $  3,584,789       $  6,235,929
Cost of Sales                                       836,677          1,977,544          2,743,673          4,503,017
                                               ------------       ------------       ------------       ------------
Gross Margin                                        302,348            783,229            841,116          1,732,912
                                               ------------       ------------       ------------       ------------
Operating expenses:
  Engineering and product development               199,736            198,544            562,600            559,207
  General and administrative                        282,070            283,288            876,209            839,334
  Marketing and sales                               346,150            437,294          1,312,033          1,219,215
                                               ------------       ------------       ------------       ------------
      Total operating expenses                      827,956            919,126          2,750,842          2,617,756

                                               ------------       ------------       ------------       ------------
Loss from operations                               (525,608)          (135,897)        (1,909,726)          (884,844)

Interest expense - net                               22,597             39,730             76,013            112,748
                                               ------------       ------------       ------------       ------------

Net loss                                           (548,205)          (175,627)        (1,985,739)          (997,592)

Preferred dividend                                   39,624             14,579            117,580             41,195

                                               ------------       ------------       ------------       ------------
Net loss available to common shareholders      $   (587,829)      $   (190,206)      $ (2,103,319)      $ (1,038,787)
                                               ============       ============       ============       ============

Net loss per common share
     Basic and diluted                         $      (0.04)      $      (0.01)      $      (0.15)      $      (0.08)

Weighted average number of shares used
  in computing earnings per share
     Basic and diluted                           14,017,592         13,398,039         13,739,375         13,336,384


See accompanying notes to financial statements.


                                       4


                                                  HOWTEK, INC.

                                            Statements of Cash Flows



                                                       Nine Months Ended     Nine Months Ended
                                                       September 30, 2001   September 30, 2000
                                                       ------------------   -------------------
                                                          (unaudited)          (unaudited)
                                                                         
Cash flows from operating activities:
  Net loss                                                $(1,985,739)         $  (997,592)
                                                          -----------          -----------
  Adjustments to reconcile net loss
  to net cash used for operating activities:
  Depreciation                                                177,403              250,143
  Amortization                                                187,103              225,648
  Compensation expense related to issue of
     Stock Subscription Warrants                                   --               27,000
Changes in operating assets and liabilities:
    Accounts receivable                                        64,745             (886,690)
    Inventory                                                (489,312)            (393,245)
    Other current assets                                       62,732              (35,876)
    Accounts payable                                          261,286            1,219,628
    Accrued expenses                                          165,496              226,645
                                                          -----------          -----------
      Total adjustments                                       429,453              633,253
                                                          -----------          -----------

      Net cash used for  operating activities              (1,556,286)            (364,339)
                                                          -----------          -----------

Cash flows from investing activities:
  Patents, software development and other                    (101,875)             (75,640)
  Additions to property and equipment                         (75,320)             (81,690)
                                                          -----------          -----------
      Net cash used for investing activities                 (177,195)            (157,330)
                                                          -----------          -----------

Cash flows from financing activities:
  Issuance of common stock for cash                           152,258               65,974
  Issuance of preferred stock for cash                             --              200,000
  Proceeds of loan from related parties                       200,000              260,000
  Proceed of note payable                                     128,995                   --
                                                          -----------          -----------
      Net cash provided by financing activities               481,253              525,974
                                                          -----------          -----------

    Increase (decrease) in cash and equivalents            (1,252,228)               4,305
    Cash and equivalents, beginning of period               1,444,771              263,073
                                                          -----------          -----------
    Cash and equivalents, end of period                   $   192,543          $   267,378
                                                          ===========          ===========

Supplemental disclosure of cash flow information:
  Interest paid                                           $     5,265          $     5,265
                                                          ===========          ===========



During the nine months ended  September  30, 2000,  $25,000 of accrued  expenses
were converted to preferred stock of the Company.

During  the nine  months  ended  September  30,  2001,  $1,060,000  of loans and
interest  payable to  related  parties  were  converted  to common  stock of the
Company.

See accompanying notes to financial statements.


                                       5


                                  HOWTEK, INC.

                          Notes to Financial Statements

                               September 30, 2001

(1) Accounting Policies

     In the opinion of management all adjustments and accruals  (consisting only
     of  normal   recurring   adjustments)   which  are  necessary  for  a  fair
     presentation  of  operating  results  are  reflected  in  the  accompanying
     financial statements.  Reference should be made to Howtek, Inc.'s ("Howtek"
     or the  "Company")  Annual Report on Form 10-K for the year ended  December
     31, 2000 for a summary of significant  accounting policies.  Interim period
     amounts are not necessarily indicative of the results of operations for the
     full fiscal year.

(2) Loan Payable to Related Party

     The  Company  has a  Convertible  Revolving  Credit  Promissory  Note ("the
     Convertible  Note") and Revolving  Loan and Security  Agreement  (the "Loan
     Agreement")  with Mr. Robert Howard,  Chairman of the Board of Directors of
     the  Company,  under which Mr.  Howard has agreed to advance  funds,  or to
     provide  guarantees  of advances  made by third  parties in an amount up to
     $3,000,000. Outstanding advances are collateralized by substantially all of
     the assets of the Company and bear interest at prime interest rate plus 2%.
     The Convertible  Note entitles Mr. Howard to convert  outstanding  advances
     into  shares  of the  Company's  common  stock  at any  time  based  on the
     outstanding  closing market price of the Company's common stock at the time
     each advance is made. During the third quarter of 2001 the Company borrowed
     $200,000 pursuant to the Loan Agreement.

     In June 2001, Mr. Howard  converted  $510,000 of the Convertible  Note into
     369,903 shares of restricted common stock, par value $.01 per share, of the
     Company (the "Common  Stock").  In September  2001,  Mr.  Howard  converted
     $84,307 principal and accrued interest on the Convertible Note into 198,441
     shares of  restricted  common stock of the Company.  At September 30, 2001,
     $195,693  was  outstanding  under  the  Loan  Agreement.  The  Company  had
     $2,804,307 available for future borrowings.

     The  Company  has debt  evidenced  by  Secured  Demand  Notes and  Security
     Agreements  (the  "Notes") owed to Mr.  Robert  Howard.  Principal of these
     Notes is due and payable in full,  together with  interest  accrued and any
     penalties provided for, on demand. Under the terms of the Notes the Company
     agreed to pay  interest at the lower rate of (a) 12% per annum,  compounded
     monthly or (b) the maximum rate permitted by applicable law. The Notes


                                       6


                                  HOWTEK, INC.

                          Notes to Financial Statements

                               September 30, 2001


(2) Loan Payable to Related Party (continued)

     currently  bear  interest  at 12%.  Payment  of the Notes is  secured  by a
     security  interest in certain  assets of the Company.  As of September  30,
     2001, the Company owed Mr. Howard $500,000 pursuant to the Notes.

     During 1999 the Company borrowed $310,000 from Mr. Robert Howard,  pursuant
     to Convertible  Promissory  Notes (the  "Promissory  Notes").  Principal on
     these  Promissory  Notes is payable in equal payments based on the borrowed
     amount at the end of each quarter  starting March 31, 2003 through December
     31, 2006. Under the terms of the Promissory Notes the Company agreed to pay
     interest at a fixed rate of 7% per annum.  At the  Company's  option it may
     pay the interest in either cash or in  restricted  shares of the  Company's
     common stock, or in any combination thereof. Interest paid in shares of the
     Company's  common  stock will be paid at the  greater of $1.00 per share or
     the  average  per share  closing  market  price at the time  each  interest
     payment  is due.  The  Promissory  Notes  entitle  the  payees  to  convert
     outstanding  principal  due into shares of the  Company's  common  stock at
     $1.00 per share,  which was the market price of the Company's  stock at the
     date the Promissory Notes were issued.

     In September 2001, Mr. Howard converted the outstanding balance,  including
     interest,  on the Promissory Notes into 361,474 shares of restricted common
     stock of the Company.


                                       7


Item 2. Management's  Discussion and Analysis of Financial Condition and Results
        of Operations

"Safe Harbor"  Statement under the Private  Securities  Litigation Reform Act of
1995:

Certain information included in this Item 2 and elsewhere in this Form 10-Q that
are not  historical  facts contain  forward  looking  statements  that involve a
number of known and unknown  risks,  uncertainties  and other factors that could
cause the actual  results,  performance  or  achievements  of the  Company to be
materially  different  from  any  future  results,  performance  or  achievement
expressed  or  implied  by such  forward  looking  statements.  These  risks and
uncertainties  include,  but are not limited  to,  uncertainty  of future  sales
levels, protection of patents and other proprietary rights, the impact of supply
and   manufacturing   constraints  or   difficulties,   possible   technological
obsolescence  of products,  competition,  ability to maintain the listing of the
Company's  common stock on the Nasdaq stock market,  and other risks detailed in
Howtek's  Securities  and  Exchange  Commission  filings.  The words  "believe",
"expect",   "anticipate"   and   "seek"   and   similar   expressions   identify
forward-looking statements. Readers are cautioned not to place undue reliance on
these forward-looking statements,  which speak only as of the date the statement
was made.

Results of Operations

Quarter Ended  September  30, 2001 compared to Quarter Ended  September 30, 2000
and Nine Months Ended September 30, 2001 compared to Nine Months Ended September
30, 2000

Sales.  Sales for the three months  ended  September  30, 2001 were  $1,139,025,
compared  with sales of  $2,760,773  for the quarter  ended  September 30, 2000.
Sales for the nine months ended  September  30, 2001 were  $3,584,789,  compared
with sales of $6,235,929 for the comparable  period in 2000. As expected,  sales
of  the  Company's  prepress  and  graphic  arts  products,   including  related
maintenance  and repair  services,  decreased by $329,877,  from $665,484 in the
third  quarter  of 2000 to  $335,607  in the  comparable  period  in  2001,  and
decreased by $1,840,669, from $3,003,899 to $1,163,230 for the nine months ended
September 30, 2000 and 2001, respectively.

The  Company  continues  to  emphasize  its medical  and  photographic  business
opportunities,  while  managing  the decline in it's  traditional  graphic  arts
business.  Sales of the Company's  medical imaging products  decreased  slightly
from $647,132 in the quarter ended September 30, 2000 to $590,231 in the quarter
ended  September 30, 2001.  Medical sales  increased to $1,644,100  for the nine
months ended  September 30, 2001 from  $1,638,763 for the  comparable  period in
2000.

Howtek's  medical  product sales are made primarily to the Company's  respective
"integration partners" or resellers,  which add software and other components to
Howtek's  products to provide full medical imaging solutions to their customers.
The Company  believes  that there has been a softening in the  telemedicine  and
Picture  Archiving  and  Communication  System  (PACS)  segments  of the medical
marketplace,  as customer  purchases  are being  deferred or  reconsidered  as a
result of what is perceived to be an increasing overall softness in the economy.
To address this the Company has increased  the number of resellers  offering the
Howtek  digitizers  into the  telemedicine  and  large-scale  PACS markets.  The
increases in resellers are expected to contribute to increased  sales of medical
products in future  periods.


                                       8


The  Company  has  made a  significant  investment  in  time  and  resources  in
developing  and  supporting  OEM  customers  using its  digitizers  in  computer
assisted  diagnosis of breast cancer systems and applications.  Products offered
by two of the  Company's  OEM  customers are in the final stage of review by the
FDA. If approved,  sales in the United  States can  commence,  with  significant
benefits anticipated for Howtek.

Howtek has also introduced its new  FilmFunnel(TM) and  ImageFunnel(TM)  systems
for commercial sale. These systems couple Howtek  digitizers with image view and
media-burning  capabilities and includes  Howtek's  portable  MyLivingRecord(TM)
image  viewing  solutions.  The  Company  expects  that  these  will  offer film
libraries,  radiology departments and individuals,  a cost-effective approach to
the  duplication,   distribution  and  personal  retention  of  medical  images.
FilmFunnel and ImageFunnel  systems are expected to contribute  higher per sales
revenues and margins  than current  digitizer  sales,  while the  MyLivingRecord
media component creates the potential for recurring, consumables revenues. These
markets,  which  are new to the  Company,  are  expected  by the  Company  to be
comparatively resistant to an increasingly adverse economic environment.

Sales of the Company's FotoFunnel(TM) photo print scanning system decreased from
$1,448,157 in the quarter  ended  September 30, 2000 to $213,187 for the quarter
ended September 30, 2001, and decreased $815,809 from $1,593,267 to $777,458 for
the nine months  ended  September  30, 2000 and 2001,  respectively.  Almost all
FotoFunnel sales for the third quarter of 2000 were made to one reseller,  which
purchased the scanners in connection with an Internet-driven business model that
proved unsuccessful.  The Company has since established  alternative positioning
and distribution  channels for the FotoFunnel  product line,  including  Noritsu
America  Corporation,  which offers and promotes  the  FotoFunnel  scanner as an
accessory with certain of its minilab and photo-finishing  products. The Company
is now  participating in FotoFunnel field evaluation and testing programs with a
variety of retail and photo chains and mass  merchants  which  precede  purchase
decisions by such buyers

Gross  Margins.  Gross  margins  for the  three  and nine  month  periods  ended
September  30,  2001  decreased  to  27%  and  23%,   respectively,   from  28%,
respectively,  in the comparable  periods in 2000. This decrease  results from a
reduction in sales without a corresponding  reduction in production overhead and
indirect production expenses. The Company intends to pursue further decreases in
overhead and indirect  production  expenses,  as it continues its cost reduction
efforts.  The  Company  expects  margins to  improve as a result of  anticipated
increases in sales of higher margin medical  digitizers and FotoFunnel  products
over the next several quarters.

Engineering and Product  Development.  Engineering and product development costs
for the three and nine month periods ended September 30, 2001 increased slightly
from   $198,544  and  $559,207  in  2000  to  $199,736  and  $562,600  in  2001,
respectively.  The Company expects  engineering and product development costs to
increase in absolute terms in 2001,  while  declining as a percentage of overall
sales.

General and  Administrative.  General and  administrative  expenses in the three
month period ended  September 30, 2001 decreased  slightly from $283,288 in 2000
to $282,070  in 2001.  General and  administrative  expenses  for the nine month
period ended  September  30, 2001  increased  slightly


                                       9


from  $839,334  in 2000 to $876,209 in 2001.  The  Company  expects  general and
administrative  expenses to remain relatively  constant in absolute terms during
the balance of 2001, and to decline as a percentage of sales.

Marketing and Sales  Expenses.  Marketing and sales  expenses in the three month
period ended  September 30, 2001 decreased 21% from $437,294 in 2000 to $346,150
in 2001.  Marketing and sales expenses for the nine month period ended September
30, 2001  increased 8% from  $1,219,215 in 2000 to $1,312,033 for the comparable
period in 2001.  During  the  second  and third  quarter  of 2001,  the  Company
significantly  reduced expenses related to its traditional graphic art business.
The increase in marketing and sales expenses  resulted  primarily from increases
in  advertising,  trade show and  promotional  expenses  related to medical  and
FotoFunnel  products.  The  Company  expects  marketing  and sales  expenses  to
increase in 2001 compared to 2000.

Interest  Expense.  Net  interest  expense for the three and nine month  periods
ended  September 30, 2001 decreased to $22,597 and $76,013 in 2001, from $39,730
and  $112,748  in 2000.  This  decrease is due  primarily  to a decrease in loan
balances  and an  increase in interest  income  related to higher cash  balances
which  were a result  of the funds  raised  from the sale of  securities  in the
fourth quarter of 2000.

As a result of the  foregoing,  the  Company  recorded a net loss of $548,205 or
$0.04 per share for the three month period ended  September 30, 2001 on sales of
$1,139,025  compared  to a net loss of $175,627 or $0.01 per share from the same
period  in 2000 on sales of  $2,760,773.  The  loss  for the nine  months  ended
September  30,  2001 was  $1,985,739  or $0.15 per share on sales of  $3,584,789
compared with  $997,592 or $0.08 per share on sales of  $6,235,929  for the nine
months ended September 30, 2000.

Liquidity and Capital Resources

The Company's ability to generate cash adequate to meet its requirements depends
primarily on operating  cash flow and the  availability  of a $3,000,000  credit
line under a Convertible Note and Revolving Loan and Security Agreement with its
Chairman,  Mr. Robert Howard, of which $2,804,307 was available at September 30,
2001.

At  September  30, 2001 the Company had current  assets of  $4,256,120,  current
liabilities  of  $2,597,038  and  working  capital of  $1,659,082.  The ratio of
current assets to current liabilities was 1.6:1.

The Company has debt evidenced by Secured  Demand Notes and Security  Agreements
(the  "Notes") owed to Mr.  Robert  Howard.  Principal of these Notes is due and
payable in full,  together with interest accrued and any penalties provided for,
on demand.  Under the terms of the Notes the Company  agreed to pay  interest at
the lower rate of (a) 12% per annum,  compounded monthly or (b) the maximum rate
permitted by applicable law. The Notes  currently bear interest at 12%.  Payment
of the Notes is secured by a security interest in certain assets of the Company.
As of September 30, 2001, the Company owed Mr. Howard  $500,000  pursuant to the
Notes.


                                       10


During 1999 the Company  borrowed  $310,000 from Mr. Robert Howard,  pursuant to
Convertible  Promissory  Notes  (the  "Promissory  Notes").  Principal  on these
Promissory  Notes is payable in equal payments  based on the borrowed  amount at
the end of each quarter starting March 31, 2003 through December 31, 2006. Under
the terms of the Promissory  Notes the Company agreed to pay interest at a fixed
rate of 7% per annum. At the Company's  option it may pay the interest in either
cash  or in  restricted  shares  of  the  Company's  common  stock,  or  in  any
combination thereof.  Interest paid in shares of the Company's common stock will
be paid at the  greater  of $1.00 per  share or the  average  per share  closing
market  price at the time each  interest  payment is due. The  Promissory  Notes
entitle  the  payees to convert  outstanding  principal  due into  shares of the
Company's  common  stock at $1.00 per share,  which was the market  price of the
Company's stock at the date the Promissory Notes were issued. In September 2001,
Mr.  Howard  converted  the  outstanding  balance,  including  interest,  on the
Promissory Notes into 361,474 shares of restricted common stock of the Company.

In September 2001, Mr. Howard converted  $84,307  principal and accrued interest
on the  Convertible  Note into 198,441 shares of restricted  common stock of the
Company.  At  September  30,  2001,  $195,693  was  outstanding  under  the Loan
Agreement.

Item 3. Quantitative and Qualitative Disclosures about Market Risk

     Not applicable.


                                       11


PART II  OTHER INFORMATION

Item 2. Sale of Securities and Use of Proceeds

In September 2001, Mr. Howard converted  $84,307 of the Convertible Note and the
outstanding  balance,  including interest,  on the Promissory Notes into 460,659
shares of restricted  common stock of the Company.  These shares of common stock
were issued  pursuant to the  exemption  from  registration  provided by Section
3(a)(9) of the Securities Act of 1933.

Item 4. Submission of Matters to a Vote of Security Holders

On August 14, 2001, the Company held an Annual Meeting of  Stockholders at which
(i) the election of directors,  (ii) adoption of the Company's 2001 Stock Option
Plan and  (iii)  ratification  of the  appointment  of BDO  Seidman,  LLP as the
Company's independent auditors for the fiscal year ending December 31, 2001. The
results of the vote were as follows:

i. Election of Directors

     Robert Howard,  W. Scott Parr, Ivan Gati, James Harlan,  Kit Howard,  Brett
Smith and Harvey Teich were elected to serve as members of the  Company's  Board
of Directors  for the ensuing year and until the election and  qualification  of
their successors.

The votes cast by stockholders with respect to the election of Directors were as
follows:

                                                       Number of
Names of Nominees         Number of Votes For          Votes Withheld
- -----------------         -------------------          --------------

Robert Howard             11,516,325                   32,791
W. Scott Parr             11,506,825                   42,291
Ivan Gati                 11,527,325                   21,791
James Harlan              11,527,325                   21,791
Kit Howard                11,523,825                   25,291
Brett Smith               11,527,325                   21,791
Harvey Teich              11,528,325                   20,791


ii. Adoption of 2001 Stock Option Plan


Votes             Votes Cast           Votes            Broker
Cast For            Against          Abstaining        Non-Votes
- --------          ----------         ----------        ---------

5,481,308          185,586            66,225          5,815,997


                                       12


iii. Appointment of Independent Auditors

Votes                    Votes Cast                  Votes
Cast For                  Against                  Abstaining
- --------                 ----------                ----------

11,527,520                 11,146                    10,450


Item 6. Exhibits and Reports on Form 8-K

     (a) Exhibits
          None

     (b) No  reports on Form 8-K were filed  during the  quarter  for which this
         report is filed.


                                       13


                                   Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the Company
has duly  caused  this  report  to be signed  on its  behalf by the  undersigned
thereunto duly authorized.


                                                       Howtek, Inc.
                                          -----------------------------------
                                                        (Company)


Date:    November 13, 2001                By:
    -----------------------------            ----------------------------------
                                             W. Scott Parr
                                             President, Chief Executive Officer,
                                             Director


Date:    November 13, 2001                By:
    -----------------------------            ----------------------------------
                                             Annette L. Heroux
                                             Vice President Finance,
                                             Chief Financial Officer



                                       14